Patrick Lamy - Net Worth and Insider Trading

Patrick Lamy Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Patrick Lamy owns 1 companies in total, including Akero Therapeutics Inc (AKRO) .

Click here to see the complete history of Patrick Lamy’s form 4 insider trades.

Insider Ownership Summary of Patrick Lamy

Ticker	Comapny	Transaction Date	Type of Owner
AKRO	Akero Therapeutics Inc	2023-01-10	See Remarks

Patrick Lamy Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Patrick Lamy Ownership Network

Ownership Network List of Patrick Lamy

No Data

Ownership Network Relation of Patrick Lamy

Patrick Lamy Owned Company Details

What does Akero Therapeutics Inc do?

Who are the key executives at Akero Therapeutics Inc?

Patrick Lamy is the See Remarks of Akero Therapeutics Inc. Other key executives at Akero Therapeutics Inc include Chief Operating Officer Jonathan Young , director & President & CEO Andrew Cheng , and Chief Development Officer Catriona Yale .

Akero Therapeutics Inc (AKRO) Insider Trades Summary

Over the past 18 months, Patrick Lamy made no insider transaction in Akero Therapeutics Inc (AKRO). Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 343,870 shares made by Andrew Cheng , a net sale of 69,475 shares made by Jonathan Young , and a net sale of 77,268 shares made by Catriona Yale .

In summary, during the past 3 months, insiders sold 110,332 shares of Akero Therapeutics Inc (AKRO) in total and bought 0 shares, with a net sale of 110,332 shares. During the past 18 months, 2,361,483 shares of Akero Therapeutics Inc (AKRO) were sold and 1,320,000 shares were bought by its insiders, resulting in a net sale of 1,041,483 shares.

Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Akero Therapeutics Inc Insider Transactions

No Available Data

Patrick Lamy Mailing Address

Above is the net worth, insider trading, and ownership report for Patrick Lamy. You might contact Patrick Lamy via mailing address: Akero Therapeutics, Inc., 601 Gateway Boulevard, Suite 350, South San Francisco Ca 94080.

Discussions on Patrick Lamy

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.